PEDRINI: "Disciplina della ricerca e della produzione di 'farmaci orfanì " (295)

This procedure concerns the rules for researching and producing orphan drugs, which are medicines for rare diseases. It aims to ensure these vital treatments are available to patients who need them. This regulation will affect pharmaceutical companies involved in rare disease drug development and patients suffering from rare conditions. It may influence the availability and cost of these specialized medicines.